Anavex Life Sciences Corp. (AVXL)

NASDAQ: AVXL · Real-Time Price · USD

8.48

+0.24 (2.85%)

At close: Nov 20, 2024, 4:00 PM

8.45

-0.03 (-0.29%)

After-hours: Nov 20, 2024, 7:12 PM EST

Anavex Life Sciences Market Cap

Anavex Life Sciences has a market cap or net worth of $718.64 million as of November 21, 2024. Its market cap has increased by 41.21% in one year.

Market Cap

718.64M

Enterprise Value

579.89M

1-Year Change

41.21%

Ranking

#2737

Market Cap Chart

Since January 25, 2007, Anavex Life Sciences's market cap has increased from $59.50M to $718.64M, an increase of 1,107.80%. That is a compound annual growth rate of 14.99%.

Market Cap History

Date	Market Cap	% Change
Nov 20, 2024	718.60M	-5.97%
Dec 29, 2023	764.20M	5.86%
Dec 30, 2022	721.90M	-45.24%
Dec 31, 2021	1.32B	264.55%
Dec 31, 2020	361.60M	148.69%
Dec 31, 2019	145.40M	100.00%
Dec 31, 2018	72.70M	-48.95%
Dec 29, 2017	142.40M	-9.24%
Dec 30, 2016	156.90M	-18.58%
Dec 31, 2015	192.70M	1,752.88%
Dec 31, 2014	10.40M	11.83%
Dec 31, 2013	9.30M	-61.09%
Dec 31, 2012	23.90M	-28.01%
Dec 30, 2011	33.20M	-63.79%
Dec 31, 2010	91.70M	102.88%
Dec 31, 2009	45.20M	-12.23%
Dec 31, 2008	51.50M	-48.91%
Dec 31, 2007	100.80M	69.41%
Jan 25, 2007	59.50M	-

View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
IRADIMED CORPORATION	639.63M
Ironwood Pharmaceuticals	635.31M
Definitive Healthcare	630.51M
agilon health	630.39M
Oculis Holding AG	627.50M
Stoke Therapeutics	619.18M
Tourmaline Bio	615.94M
Entrada Therapeutics	615.35M

Market Cap Rankings